| SCHEDULE OF EARNINGS PER SHARE |
SCHEDULE
OF EARNINGS PER SHARE
| | |
2026 | | |
2025 | |
| | |
For the three months ended March 31, | |
| | |
2026 | | |
2025 | |
| Basic Earnings (Loss) Per Share: | |
| | | |
| | |
| Net income (loss) attributable to Class A common stockholders | |
$ | 510,510 | | |
$ | (441,731 | ) |
| Net income (loss) attributable to Class B common stockholders | |
| 1,624,196 | | |
| (1,504,276 | ) |
| Net income (loss) attributable to common stockholders | |
| 1,624,196 | | |
| (1,504,276 | ) |
| Total net income (loss) attributable to Snail Inc. | |
$ | 2,134,706 | | |
$ | (1,946,007 | ) |
| Class A weighted average shares outstanding - basic | |
| 9,036,135 | | |
| 8,442,025 | |
| Class B weighted average shares outstanding - basic | |
| 28,748,580 | | |
| 28,748,580 | |
| Class A and B basic earnings (loss) per share | |
$ | 0.06 | | |
$ | (0.05 | ) |
| | |
| | | |
| | |
| Diluted Earnings (Loss) Per Share: | |
| | | |
| | |
| Net income (loss) attributable to Class A common stockholders | |
$ | 510,510 | | |
$ | (441,731 | ) |
| Dilutive effects of convertible notes | |
| 333 | | |
| — | |
| Dilutive effects of convertible notes warrants | |
| — | | |
| (63,515 | ) |
| Dilutive effects of equity line of credit warrants | |
| — | | |
| (16,147 | ) |
| Net income (loss) attributable to Class A common stockholders | |
$ | 510,843 | | |
$ | (521,393 | ) |
| Net income (loss) attributable to Class B common stockholders | |
$ | 1,624,196 | | |
$ | (1,504,276 | ) |
| Net income (loss) attributable to common stockholders, Basic | |
$ | 1,624,196 | | |
$ | (1,504,276 | ) |
| Dilutive effects of convertible notes warrants | |
| — | | |
| (216,296 | ) |
| Dilutive effects of equity line of credit warrants | |
| — | | |
| (54,986 | ) |
| Net income (loss) attributable to Class B common stockholders | |
$ | 1,624,196 | | |
$ | (1,775,558 | ) |
| Net income (loss) attributable to common stockholders, Diluted | |
$ | 1,624,196 | | |
$ | (1,775,558 | ) |
| Class A weighted average shares outstanding - basic | |
| 9,036,135 | | |
| 8,442,025 | |
| Dilutive effects of convertible notes | |
| 493,261 | | |
| — | |
| Dilutive effects of convertible notes warrants | |
| — | | |
| 717,045 | |
| Dilutive effects of equity line of credit warrants | |
| — | | |
| 82,752 | |
| Class A weighted average shares outstanding - diluted | |
| 9,529,396 | | |
| 9,241,822 | |
| Class B weighted average shares outstanding - basic | |
| 28,748,580 | | |
| 28,748,580 | |
| Weighted average shares outstanding - basic | |
| 28,748,580 | | |
| 28,748,580 | |
| Dilutive effects of convertible note warrants | |
| — | | |
| — | |
| Dilutive effects of convertible note warrants, shares | |
| — | | |
| — | |
| Class B weighted average shares outstanding - diluted | |
| 28,748,580 | | |
| 28,748,580 | |
| Weighted average shares outstanding - diluted | |
| 28,748,580 | | |
| 28,748,580 | |
| Diluted earnings (loss) per Class A share | |
$ | 0.05 | | |
$ | (0.06 | ) |
| Diluted earnings (loss) per Class B share | |
$ | 0.06 | | |
$ | (0.06 | ) |
| Diluted
earnings (loss) per share | |
$ | 0.06 | | |
$ | (0.06 | ) |
|
| SCHEDULE OF ANTI-DILUTIVE SHARES AND SECURITIES |
The
following table provides a listing of shares excluded from the calculation of Diluted EPS due to their anti-dilutive effects:
SCHEDULE OF ANTI-DILUTIVE SHARES AND SECURITIES
| | |
2026 | | |
2025 | | |
Method | |
| | |
For the three months ended March 31, | | |
| |
| | |
2026 | | |
2025 | | |
Method | |
| Excluded Shares: | |
| | | |
| | | |
| | |
| Restricted stock units outstanding | |
| 1,160,691 | | |
| 1,129,455 | | |
| Treasury | |
| Equity line of credit warrants | |
| 334,314 | | |
| — | | |
| Treasury | |
| Underwriters warrants | |
| — | | |
| 120,000 | | |
| Treasury | |
| Convertible notes | |
| 2,124,229 | | |
| 1,313,632 | | |
| If-Converted | |
| Convertible notes warrants | |
| 1,216,185 | | |
| — | | |
| Treasury | |
| Antidilutive securities | |
| 1,216,185 | | |
| — | | |
| Treasury | |
|